Computational probing of Toxoplasma gondii major surface antigen 1 (SAG1) for enhanced vaccine design against toxoplasmosis.

The SAG1 is a tachyzoite-specific protein critical for Toxoplasma gondii (T. gondii) adhesion to surface receptors of the host cells. In this study we've comprehensively excavated the sequence of SAG1 using online bioinformatics servers toward better vaccine design against toxoplasmosis. Web-based tools were used to assess the physico-chemical properties, post-translational modifications (PTMs), transmembrane domains, subcellular localization, secondary and 3D structures, as well as B-cell, Cytotoxic T cells (CTL) and major histocompatibility complex (MHC) epitopes. The 336 amino acid sequence possessed a molecular weight of 34829.02 D, aliphatic index of 80.15 and GRAVY score of 0.129. There was 47 PTM sites without any transmembrane domains. Also, the SAG1 protein was appointed to be immunogen and non-allergen. The secondary structure comprised 62.5% random coil, 26.79% extended strand and 10.71% alpha helix. Ramachandran plot of the refined model demonstrated 94.4% residues in the favored region, 4.8% in allowed region and 0.8% in outlier region. Additionally, various potential B-cell (linear and conformational), CTL and HTL epitopes were predicted for T. gondii SAG1. This in silico investigation would be a premise for appropriate immunization strategies against toxoplasmosis. More studies are anticipated to be done empirically using SAG1 immunoprotective epitopes combined with other antigenic compounds.